Thousands of children and young people in the United States struggle with lupus. The treatment of the condition requires more aggressive drugs than for adult patients and the adverse effects of the drugs impact biological, psychological, and social development. To study the issue, a team of researchers at the Children’s Hospital…
Researchers at Monash University’s Department of Immunology recently developed a method to prevent lupus by targeting a specific receptor in B cells. B cells are a key type of immune cell responsible for defending the body against infections, producing antibodies and generating memory B cells that remain in the body so that, if encountering…
A team led by researchers at Garvan Institute of Medical Research and St. Vincent’s Clinical School in Australia identified a new trigger for autoimmune diseases. The study was recently published in the journal Immunity and is entitled “FAS Inactivation Releases Unconventional Germinal…
Patients who suffer from systemic lupus erythematosus (SLE) or lupus nephritis (LN) may have seven new therapeutic options by 2022, according to a new report on the global drug market. The forecast published by the company Research and Markets analyzed the lupus treatment market over the past few decades,…
Results from a survey conducted by GfK in 2014 indicated that patients with systemic lupus erythematosus (SLE) have difficulties describing their symptoms to their physicians, leading to a gap in physicians’ understanding of the full impact the illness has on these patients’ lives. The survey was conducted by GfK on…
Inducing ovarian suppression in female patients with childhood-onset systemic lupus erythematosus (SLE) is protective against ovarian failure from treatment with cyclophophamide. A clinical trial from Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine has established a safe dose of triptorelin that effectively achieves and maintains complete…
A study recently published in the journal Arthritis & Rheumatology revealed that proteinuria is an accurate clinical predictor of long-term renal outcome in patients with lupus nephritis. The study was conducted by an international research team and is entitled “Predictors of Long-Term Renal Outcome…
Researchers at the Massachusetts General Hospital and University of North Carolina (UNC) Kidney Center recently published in the journal Arthritis Research & Therapy a review on important aspects concerning the design of clinical trials for lupus nephritis. The study is entitled “Comparison and…
The Lupus Foundation of America is involved in an initiative named “Ask the Experts” based on a series of educational presentations focusing on several topics related to lupus. This initiative is a free service that allows participants to learn about the disease and ask questions to world’s leading lupus…
A recently published study led by Australian researchers from Monash University in Victoria has shown an association between Vitamin D levels and Lupus (SLE) disease activity. The study entitled, “Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort,” was published…